- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03115320
Frozen-thawed Embryo Transfer in a Naturally Stimulated Cycle: Does hCG Triggering Bring Any Advantage in Comparison to Testing LH Surge With Home Tests?
June 1, 2020 updated by: Tampere University Hospital
A Protocol for a Randomized, Two-Parallel-group Study to Compare the Efficacy of Testing LH Surge at Home Versus Medically Triggered Ovulation With hCG (Pregnyl®) in the Naturally Stimulated Cycle in the Frozen-thawed Embryo Transfer
The primary aim of this study is to find out if ovulation triggered with hCG provides any additional benefit in comparison to spontaneous LH surge measured with the home test when transferring frozen-thawed embryo in a naturally stimulated cycle.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
62
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tampere, Finland
- Tampere University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 42 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- - Patient with IVF or ICSI cycle and therefore having frozen-thawed embryos
- Regular menstruation cycle
- Patient's willingness to participate in the study
Exclusion Criteria:
- - Irregular menstrual cycle demanding preparing endometrium with hormones for frozen-thawed embryo
- No frozen embryos after IVF cycle
- Allergy to Pregnyl® or some of its ingredients in the medication or other contraindications due to Pregnyl®
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pregnyl (Human chorionic gonadotropin)
In this group, patients have natural cycle in frozen-thawed embryo transfer and the ovulation is confirmed by administration of hCG (Pregnyl® 5000 IU).
The day of transferring embryo is depending on the day of administration of hCG and the age of the embryo.
The day zero day is defined by ovulation triggered by hCG.
|
Human chorionic gonadotropin (Pregnyl, 5000IU) is used in the medication group to confirme the ovulation.
Other Names:
|
Other: Home ovulation test
The patients randomized to the LH surge group perform the ovulation home test daily from the urine.
Thus, the ovulation in this group is corfimed by the urine test.
The day of transferring embryo is depending on the positive ovulation test and the age of the embryo.
The day zero day is defined by positive ovulation test.
|
The ovulation in the natural menstrual cycle is confirmed by the home ovulation tests from the urine.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Live birth rate
Time Frame: At possible delivery (about 40 weeks)
|
At possible delivery (about 40 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Ongoing pregnancy rate
Time Frame: After two weeks
|
After two weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Helena Tinkanen, Tampere University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2017
Primary Completion (Actual)
November 1, 2019
Study Completion (Actual)
December 1, 2019
Study Registration Dates
First Submitted
November 17, 2016
First Submitted That Met QC Criteria
April 10, 2017
First Posted (Actual)
April 14, 2017
Study Record Updates
Last Update Posted (Actual)
June 4, 2020
Last Update Submitted That Met QC Criteria
June 1, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R16172M
- 2016-003959-29 (EudraCT Number)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Human chorionic gonadotropin
-
Beijing Children's HospitalUnknownKallmann Syndrome | Hypogonadotropic HypogonadismChina
-
Ferring PharmaceuticalsCompleted
-
Royan InstituteCompletedEndocrine System Diseases | Gonadal DisordersIran, Islamic Republic of
-
Michigan State UniversityCompleted
-
Ain Shams UniversityCompletedRepeated Implantation FailureEgypt
-
Cairo UniversityAdam International Hospital; Nile Ivf Center, Cairo, EgyptCompleted
-
Tongji HospitalRecruitingInfertility | Kallmann Syndrome | Isolated Hypogonadotropic HypogonadismChina
-
ART Fertility Clinics LLCCompleted
-
Martin Blomberg JensenCompleted
-
IVI MadridCompleted